FDA Investigating Hospitalizations Linked to Counterfeit Ozempic
WEDNESDAY, Nov 8, 2023 (HealthDay News) — The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides. At least one of these reports includes mention of a counterfeit version of theContinue Reading